Collection

see My Collection

zero Useful+1

zero

Bendallysine eye drops

Announce Upload video

Bendallysine eye drops are suitable for early senile cataract.

Drug name: Bendallysine eye drops

Drug type: OTC Class A, external medicine
Use classification: Other ophthalmic drugs

catalog

thirteen packing
fourteen term of validity
fifteen Executive standards

Composition

Announce

edit

Each 8 ml solution of this product contains 40 mg of Bendallysine: auxiliary materials are: sodium dihydrogen phosphate, disodium hydrogen phosphate, sodium chloride, hydroxypropyl methylcellulose, benzalkonium chloride, and water for injection.

character

Announce

edit

This product is colorless or almost colorless clear liquid.

Action category

Announce

edit

This product is an ophthalmic non prescription drug.

indication

Announce

edit

Early senile cataract.

Specifications

Announce

edit

8 ml: 40 mg

Usage and dosage

Announce

edit

Eye drops. Three times a day, 1-2 drops each time or according to the doctor's advice.

Adverse reactions

Announce

edit

Transient burning sensation, tears and other reactions, but can adapt with the prolongation of medication time. Difficulty in swallowing, nausea, vomiting, diarrhea, tears, contact dermatitis, etc. are rare.

taboo

Announce

edit

In case of eye injury and serious infection, do not use it temporarily, or follow the doctor's advice.

matters needing attention

Announce

edit

1. Do not let the nozzle contact hands and eyes during eye drops to avoid polluting the eye drops in the bottle.

2. Please control the bottle cap tightly after use to prevent pollution.

3. Some cases have temporary irritation, such as burning sensation, tingling, etc., which does not affect the use. The experiment proved that this product can reduce the incidence and intensity of irritation after being refrigerated in the refrigerator (about 4 ℃). It is recommended that patients with irritation during use should put this product into the refrigerator for refrigeration to reduce irritation. If you find that the liquid medicine is polluted or turbid, please discard it.

4. It is reported that the incidence and intensity of transient irritation are related to other eye infections or inflammations. It is recommended that cataract patients with eye infections or inflammations should treat the above eye diseases at the same time under the guidance of doctors when using this product.

5. It is forbidden for people who are allergic to this product. People with allergic constitution should use it with caution.

6. It is forbidden to use this product when its properties change.

7. Please keep this product out of the reach of children.

8. If you are using other drugs, please consult a doctor or pharmacist before using this product.

Drug interaction

Announce

edit

If it is used together with other drugs, drug interaction may occur. For details, please consult a doctor or pharmacist.

pharmacological action

Announce

edit

This product is an aldose reductase (AR) inhibitor. The literature reports that it has an inhibitory effect on lens aldose reductase (AR). Therefore, BDZL eye drops are used to inhibit the activity of AR in the eyes, so as to achieve the purpose of preventing or treating cataract.